Mailing Address
45 Rockefeller Plaza, 20th Floor, New York, NY 10111
212-268-1002
Washington DC Office
1101 14th Street NW, Suite 850, Washington, DC 20005
866-399-6262 (Toll Free) | 202-331-2292 (Fax)
Make an online donation today.
Mail your contributions to the address below:
Ovarian Cancer Research Alliance
Post Office Box 32141
New York, NY 10087-2141
Tax ID #13-3806788
We’re here for you! Our Patient Support team is available to take your calls Monday – Friday. Call 212-268-1002 and if no one is available when you call, someone will get back to you within 24 hours.
For all press inquiries, please contact:
Amanita Duga-Carroll
ADC Strategic Communications, Inc.
After months of dedicated advocacy alongside survivors, families, and clinicians, the bipartisan Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act has officially been introduced in Congress. Championed by Senators Elissa Slotkin (D-MI) and Katie Britt (R-AL) in the Senate, and Representatives Rosa DeLauro (D-CT-03) and Don Bacon (R-NE-01) in the House, this bill … Continued
Dear Friends, Every day, I’m reminded that this community doesn’t wait for change—it builds it, together. That’s true across everything OCRA does, and it’s true of the impact we have made, with your help, through our September fundraising campaign. Because so many of you have stepped forward, we’ve extended our goal to $350,000. Every gift … Continued
Watch expert sessions on ovarian, endometrial, cervical, and rare gynecologic cancers, and more This September, more than 2,180 people from 65 countries came together for OCRA’s 2026 International Gynecologic Cancer Conference® to learn the latest updates, gain resources for navigating gynecologic cancer, and find support, community, and hope. If you couldn’t join us live, or … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
